Purpose: The relationship between cancer screening activities in Europe and the health systems in which they are embedded varies, with some screening programs organized largely separately and others using existing health service staff and facilities. Whatever the precise arrangements, the opportunity for screening to achieve health gain depends on many elements interacting within and beyond the health system, from an accurate register identifying the target population to a means to ensure and monitor follow-up.
that quality assurance and adherence to guidelines were important, even though they generated low scores in the experiment. This difference may be due some attributes being interrelated, more wide-ranging or the sequential nature of establishing an effective screening program, with guidelines being the first stage of the process.
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| INTRODUCTION
What makes an effective cancer screening program? This is a key question for researchers and policy makers aiming to improve cancer screening programs in Europe. Cancer screening activities in Europe are embedded within wider health systems, but their relationships with them vary. Some are organized largely separately, with their own staff and facilities, and others using existing resources, as examinations are undertaken, either opportunistically or within an organized framework, by gynecologists and other physicians in their own premises. However, whatever the precise arrangements, the opportunity for screening to achieve health gain depends on the interaction of many elements within and beyond the health system, from an accurate register identifying the target population to a means to ensure and monitor follow up, such as linkage to a cancer registry. Consequently, those responsible for cancer screening must look beyond the aspects of the process over which they have direct control.
The EU-TOPIA project (towards improved screening for breast, cervical, and colorectal cancer in all of Europe) aims to optimize screening in Europe. 1 Although the European Council issued comprehensive recommendations for breast, cervical, and colorectal cancer screening in Europe, performance indicators show that there is still a need to develop more effective population-based screening programs in Europe. [2] [3] [4] [5] As demonstrated in previous studies by the authors, [6] [7] [8] there remain many barriers to effective cancer screening within broader health systems and beyond. Defining an effective screening program is one step in the process towards improvement and overcoming these system barriers.
Given the growing burden of health care and the limited resources available, there is a need for researchers and policy makers to prioritize areas for attention. Choice experiments offer a means to identify the importance attributed to different factors affecting health-care delivery while taking account of the real life trade-offs that need to be made in an environment of limited resources. Previous experiments of this type of methodology have been used to assess patient preferences for cancer screening, thereby informing the design and operation of services. 9, 10 This focus reflects the preponderance, in the literature on barriers to effective screening, of barriers to individual participation rather than service or system level barriers (a systematic review by the authors has been submitted for publication elsewhere). This experiment aims to readdress the balance of evidence by investigating the attitudes and beliefs of those responsible for the organization of screening programs at a national and regional level.
| METHODS
We used a conjoint analysis methodology incorporating a single ranking exercise. Our methodology was informed by a review of the available literature, 11-14 a systematic literature review of discrete choice methods, 15 and insights gained from prior studies conducted by the authors. [16] [17] [18] As shown in Figure 1 , the conjoint methodology included four key stages. The first stage is to identify a list of key attributes that we believe, based on the available evidence, to be essential for an effective screening program. For example, as will be described later, one attribute of a screening program is that it uses a register that includes the entire population. Each attribute has a series of levels. Using the same example, we selected only two possible levels, yes, such a register is used, or no, none is used. It would be possible to have had more levels, for example, with three levels, a register that covered 100%, 70 to 99%, and less than 70%. However, we had no sound basis for choosing these thresholds. The second stage is to generate profiles of screening programs, each specifying one level for each attribute. Thus, in the example above, some profiles would include a register covering the entire population and others would not. Each would also contain similar information on all the other attributes. Even with a small number of attributes and levels, the number of possible combinations is enormous, so we use the orthoplan routine in the SPSS software package 19 to generate a smaller subsample of all possible profiles. The resulting profiles have two important characteristics. They are balanced, that each level in each attribute appears the same number of times, and are orthogonal, so that every pair of levels, where one is from one attribute and one from another attribute, appears the same number of times in the design. These characteristics are necessary for the final stage. Before that, in the third stage, individuals are asked to rank all profiles from the best to worst cancer screening programs. The characteristics of the profiles that have been generated in this way, combined with the ranking by participants, are then combined in the fourth and final stage, using the conjoint routine in SPSS, to calculate weights relating to the importance placed on each attribute ("utility"). [20] [21] [22] [23] Following the conjoint experiment, we engaged in a discussion of the results with participants in the study in order to gain a better understanding of their meaning and implications.
| Establishing the attributes
Following our literature reviews, we used three key papers as a basis for establishing a list of key attributes and potential levels to use in the conjoint exercise. people with detected abnormalities, and when indicated, treatment, surveillance, and aftercare. Third, Lynge et al described essential phases of the implementation of a screening program as before planning, planning, feasibility, pilot, roll-out, running program, and sustainability. From these papers, we collated a list of attributes and then prioritized 13 of them based on knowledge obtained from previous work conducted as part of the EU-TOPIA project.
We conducted a pilot with five health-care researchers in London to assess the feasibility of the required task using the initial list of attributes. We asked the researchers to do a ranking exercise with a set of 27 profiles generated from the 13 attributes, and we then discussed their experience in a qualitative manner. The researchers were not experts in cancer screening, but this allowed us to ensure the feasibility of the exercise and provide feedback on the meaningfulness of the descriptions.
The qualitative feedback from the pilot indicated that the large number of profiles we initially considered was excessive as it was impractical to rank them in one exercise from best to worst. Consequently, we reduced the numbers of attributes from 13 to 10 and minimized the number of levels to two per attribute (as shown in Table 1) so that respondents had 12 profiles to rank, which was deemed manageable by those involved in the pilot.
The qualitative assessment of the pilot also suggested that a refinement of the attribute descriptions was required to facilitate the exercise. The initial short descriptions were considered to be open to interpretation. We added long descriptions to add clarification ( Table 2 ).
The descriptions of the attributes and levels were then reviewed by a team of experts in cancer screening programs from six European countries taking part in the EU-TOPIA project to ensure external validity.
| Generation of profiles
We created a data file listing the 10 attributes and two alternative levels. We used a standard SPSS conjoint syntax for orthogonal design (orthoplan) [19] [20] [21] [22] to generate a series of profiles combining these attributes and levels, to generate a series of 12 profiles. Listing all combinations would generate a large number of profiles. Thus, the software generated just enough combinations that allow the authors to calculate the weights that participants give to each attribute, based on their rankings. The final result was a matrix of 12 profiles made up of 10 attributes, each with two levels ("yes" or "no"; Table 3 ).
| Ranking exercise and analysis
An online form, with a file including the 12 profiles, was created and circulated to participants. The materials included an explanation of the exercise, description of the profiles, and table for the participant to complete with their results. Generation of knowledge and effectiveness National screening organization established. Guidelines are up-to-date and evidence-based.
Maximization of uptake (informed participation) Screening uptake is systematically monitored.
Operation of the program Quality assurance system in place. Opportunistic screening is rare. Screening guidelines are adhered to.
Maximization of follow-up Process for systematic follow-up in place.
Treatment Long-term outcomes are monitored.
Copies of the materials are included in Appendices A and B. We used the conjoint analysis function within SPSS software [19] [20] [21] [22] consistent with previous studies.
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| Qualitative discussion
An EU-TOPIA project workshop was held in Budapest in September 2017 to which respondents of the survey were invited. During the workshop, a facilitated group discussion of an hour duration was held with a selection of respondents. We explored whether respondents were surprised at the results of the survey, whether they believed that all important attributes had been included, and discussed the respondents' response to the conjoint ranking methodology.
3 | RESULTS
| Sample characteristics
The sample included 66 participants from 31 countries taking part in the EU-TOPIA workshop. Respondents were mainly from cancer screening organizations, researchers, or policy-makers, whose more specific roles are shown in Figure 2 (11 did not specify their role).
| Importance scores
The results of the experiment are shown in Figure 3 and Table 4 . There was a noticeable division of results between the four most important attributes, all with an average importance factor of over 15 and the other 6 attributes that had an importance factor of less than seven. 
Category Attribute
Identification of population at risk Register used to identify population eligible for screening includes all people who require screening. Register used to identify population eligible for screening is regularly updated with changes of address, death and other criteria.
Generation of knowledge and effectiveness
There is a well-defined national screening organization responsible for assessing needs, evaluating the evidence and system design. Guidelines for cancer screening are up-to-date and evidence-based.
Maximization of uptake
The rate of informed participation is monitored and evaluated systematically, including monitoring equity of access to ensure everyone has the same opportunity to attend.
Operation of the program A system to assure the quality of screening is in place. Parallel opportunistic screening outside of the population-based screening program is not allowed to take place. Guidelines are adhered to.
Maximization of follow up and treatment
There is a procedure and process for the systematic follow up of screen-detected lesions. Monitoring of long term outcomes is established through a link between screening records and cancer registries. 
| Follow-up workshop with respondents
Methods such as this, by forcing trade-offs, can reveal preferences that would otherwise remain concealed. In the workshop discussion, participants were reluctant to accept that they had rated quality assurance as of low
FIGURE 2
The role of respondents included in the sample (n = 66) FIGURE 3 Attributes ranked most highly by participants (n = 66) importance and were surprised at this result. We explored several explanations for the difference between the results of the experiment and the group opinion with them. One explanation was that some of the attributes are sequential.
For example, guidelines can only be adhered to once in place and quality can only be assured once other attributes are developed (eg, monitoring) so those ranking profiles in the experiment may have taken this into account implicitly.
Another explanation, although less intuitive, was that guidelines are considered more wide-ranging than quality assurance and therefore ranked higher by respondents aiming to maximize their choice. Knowledge of the attributes in practice may also have influenced ranking in the experiment. For example, the group indicated that actual guidelines are sometimes based on expert opinion rather than higher-level evidence and are infrequently updated. Therefore, this issue should be prioritized as a key factor among others. Knowledge of this may affect how important this factor is in an effective screening program.
4 | DISCUSSION
| Strengths and limitations of the study
So far, much of the literature on cancer screening has focused on those elements within the organizational boundaries of organized programs. Yet, to achieve optimal outcomes, it can be argued that it is necessary to look more widely. This experiment suggests that those involved in the operation of cancer screening agree with our applied concept. We are unaware of a similar exercise being undertaken previously. Based on this experience we also suggest that performance indicators for cancer screening programs 2 should take a broader perspective in assessing effectiveness.
The study used an established methodology for conjoint analysis. [20] [21] [22] The list of attributes used in the study was formulated in several phases, including data collection (from the literature), data reduction, removing inappropriate attributes, and wording (refined as a result of the pilot and reviewed by experts) in line with recommendations in the literature. 26 The trial phase with health-care researchers and review by experts ensured external validity. In a follow-up phase, the results were validated with respondents in a qualitative manner, which also allowed a better understanding of the quantitative results. The selected sample included experts on cancer screening programs throughout Europe, with coverage of 31 countries.
The main limitation of the study was the sample size. Ideally, the sample size would have been larger. 27 However, the addition of a qualitative phase allowed us to use the quantitative results as a source for discussion and future actions. In addition, the sample focused on researchers, organizers of screening programs, and policy makers. A more extensive study might have included service providers, health professionals directly involved in the screening process, and people invited for screening. Previous research has shown that patient preferences, as perceived by health-care professionals, may differ from those of the patients themselves 28 so a comprehensive sample including all stakeholders would increase the robustness of any study.
The postexperiment discussion with respondents suggested some disagreement with the results of the experiment. Previous research in cancer screening has also shown differences when comparing the results of choice experiments versus ordinary rating, ranking, or survey questions, 29, 30 even if overall there was agreement with the attribute ranked as most important ones. 29 However, discussion at the workshop indicated that some attributes were interrelated, sequential, or more wide-ranging, and this might have affected how people ranked the profiles. For example, without implemented evidence-based guidelines, assuring quality would not be feasible. Conversely, assuring quality may make the assumption that guidelines and a screening organization have already been established. This may explain the low score for the quality assurance attribute.
| Comparison with the literature
As previously mentioned, previous conjoint studies have been conducted with cancer screening programs, but the focus has generally been on understanding patient preferences 9, 10, [31] [32] [33] [34] [35] [36] 30 and financial incentives or co-payments 30 Other studies have also investigated the impact of including labels for specific screening tests versus nonlabeling of a list of attributes. 38 In a review of the literature on breast, cervical, and colorectal cancer screening, 9 of 22 included studies on patient preferences, 15 assessed test attributes, 2 studies assessed health-care delivery, and 5 studies included both.
Test attributes had a significant effect on choice of test, and health-care delivery (how screening is organized) had a mixed effect. This review recommended further research on barriers to uptake, particularly research including healthcare delivery, as this study aims to do. Another systematic review of colorectal cancer screening 10 showed that people preferred screening to nonscreening and were willing to trade-off complications to get more clinical benefit. A similar review of 28 cancer treatment preference studies 39 found that most attributes related to outcomes (70%), while process and cost attributes only related to 25% and 5% of evidence, respectively, showing less attribute importance as well as being less often included in studies.
| Implications
There is a lack of evidence on the priorities of policy makers who are forced to make trade-offs in cancer screening.
Discrete choice methods can be used to evaluate health-care interventions, services, and policies including both outcomes and process attributes, 40,41 including priority setting. 42 As previously mentioned, when looking at patient preferences, factors such as convenience (mode of administration and location of treatment) may overlap with health service design. However, choice experiments can also be used to examine health system and service attributes. In previous studies, discrete choice has been used: (1) to assess the views of policymakers on health technology assess- 
to explore reforms to payment systems 45 ; (4) to assess pharmacy services 46 ; and (5) to inform health workforce policy. 47 These studies have demonstrated the value of choice experiments in designing health services. However, none of these studies have addressed cancer screening directly.
| CONCLUSION
This choice experiment concluded that having up-to-date and evidence-based guidelines was the most important factor in an effective screening program, followed by systematically monitoring screening uptake, having a population e42register covering all the eligible population and monitoring long-term outcomes. When required to trade-off, respondents selected these attributes rather than quality assurance or guideline adherence. The follow-up qualitative research on these priorities suggests that quality assurance and guideline adherence are also important to them.
However, the main contribution of this exercise was to stimulate a valuable discussion on the role of quality assurance and guidelines that might otherwise not have happened, and which allowed some important issues to emerge. The factors that were deemed most important in the choice experiment may be the most important ones to have in the first place, with quality assurance dependent upon them. This suggests that, where resources are limited, establishing evidence-based and up-to-date guidelines should be a priority, followed by monitoring uptake, and ensuring a comprehensive population register before developing other aspects of the screening program. However, a more comprehensive study, including a wider group of stakeholders and a more extensive list of independent attributes, would provide even more additional insights.
